{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:12:18Z","timestamp":1791972738152,"version":"4.3.4"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000038","name":"US Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jconrel.2026.114793","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:21:11Z","timestamp":1772641271000},"page":"114793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A systematic approach to develop and characterize a compositionally equivalent buprenorphine in situ forming implant (Sublocade\u00ae)"],"prefix":"10.1016","volume":"393","author":[{"given":"Surendra","family":"Poudel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudra","family":"Pangeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semih","family":"Gulec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangnan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lasaosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Gerard","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Halquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114793_bb0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","article-title":"The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis","volume":"71","author":"Ciccarone","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.jconrel.2026.114793_bb0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.7621","article-title":"Prevention of prescription opioid misuse and projected overdose deaths in the United States","volume":"2","author":"Chen","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jconrel.2026.114793_bb0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neubiorev.2018.06.010","article-title":"New synthetic opioids: part of a new addiction landscape","volume":"106","author":"Karila","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jconrel.2026.114793_bb0020","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.mayocp.2019.03.029","article-title":"Medication-assisted treatment for opioid-use disorder","volume":"94","author":"Oesterle","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jconrel.2026.114793_bb0025","author":"Garnett"},{"key":"10.1016\/j.jconrel.2026.114793_bb0030","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1001\/jamapsychiatry.2018.3126","article-title":"Prevention and treatment of opioid misuse and addiction","volume":"76","author":"Volkow","year":"2019","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.jconrel.2026.114793_bb0035","doi-asserted-by":"crossref","DOI":"10.52965\/001c.37517","article-title":"Buprenorphine and its formulations: a comprehensive review","volume":"10","author":"Poliwoda","year":"2022","journal-title":"Health Psychol. Res."},{"key":"10.1016\/j.jconrel.2026.114793_bb0040","author":"Sublocade\u00ae"},{"key":"10.1016\/j.jconrel.2026.114793_bb0045","author":"Brixardi\u00ae"},{"key":"10.1016\/j.jconrel.2026.114793_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102311","article-title":"Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial","volume":"66","author":"Marsden","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jconrel.2026.114793_bb0060","series-title":"Bodegradable N-Stu Forming Mplants and Methods of Producing the Same","author":"Dunn","year":"1990"},{"key":"10.1016\/j.jconrel.2026.114793_bb0065","doi-asserted-by":"crossref","unstructured":"Dunn RL, The Atrigel\u00ae drug delivery System, in: Rathbone MJ, Hadgraft J, Roberts MS, Lane ME (Eds.), Modified-Release Drug Delivery Technology, 1st ed., Marcel Dekker Inc. New York, 2003: pp. 647\u2013655. https:\/\/www.taylorfrancis.com\/chapters\/edit\/10.1201\/9780203910337-57\/atrigel-drug-delivery-system-richard-dunn (accessed March 10, 2025).","DOI":"10.1201\/9780203910337.ch54"},{"key":"10.1016\/j.jconrel.2026.114793_bb0070","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jconrel.2012.04.016","article-title":"In situ forming implants \u2014 an attractive formulation principle for parenteral depot formulations","volume":"161","author":"Kempe","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114793_bb0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2018025013","article-title":"In situ forming depot as sustained-release drug delivery systems","volume":"36","author":"Kanwar","year":"2019","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2026.114793_bb0080","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jconrel.2013.08.024","article-title":"PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release","volume":"172","author":"Parent","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114793_bb0085","author":"Atridox\u00ae Summary of Product Characteristics"},{"key":"10.1016\/j.jconrel.2026.114793_bb0090","author":"Eligard\u00ae"},{"key":"10.1016\/j.jconrel.2026.114793_bb0095","author":"Perseris\u00ae"},{"key":"10.1016\/j.jconrel.2026.114793_bb0100","author":"Fensolvi\u00ae"},{"key":"10.1016\/j.jconrel.2026.114793_bb0105","series-title":"Highlights of Prescribing Information","author":"Camcevi\u00ae","year":"2021"},{"key":"10.1016\/j.jconrel.2026.114793_bb0110","author":"Risvan\u00ae"},{"key":"10.1016\/j.jconrel.2026.114793_bb0115","doi-asserted-by":"crossref","unstructured":"M. Washington, D. Swiner, K. Bell, M.F.- Biomaterials, 2017, The impact of monomer sequence and stereochemistry on the swelling and erosion of biodegradable poly (lactic-co-glycolic acid) matrices, ElsevierMA Washington, DJ Swiner, KR Bell, MV Fedorchak, SR Little, TY MeyerBiomaterials, Elsevier. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0142961216306627 (accessed March 11, 2025).","DOI":"10.1016\/j.biomaterials.2016.11.037"},{"key":"10.1016\/j.jconrel.2026.114793_bb0120","series-title":"Journal of Controlled Release, 2013","article-title":"The effect of lauryl capping group on protein release and degradation of poly (d, l-lactic-co-glycolic acid) particles, ElsevierN Samadi","author":"Samadi","year":"2013"},{"key":"10.1016\/j.jconrel.2026.114793_bb0125","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jconrel.2005.10.005","article-title":"Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems","volume":"110","author":"Luan","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114793_bb0135","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/0142-9612(95)93575-X","article-title":"Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition","volume":"16","author":"Park","year":"1995","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114793_bb0140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","article-title":"The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems - a review","volume":"415","author":"Fredenberg","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114793_bb0145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0168-3659(00)00354-0","article-title":"Role of crystallization in the phase inversion dynamics and protein release kinetics of injectable drug delivery systems","volume":"70","author":"DesNoyer","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114793_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113912","article-title":"Drug release from in situ forming implants and advances in release testing","volume":"178","author":"Wang","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114793_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121777","article-title":"Novel adapter method for in vitro release testing of in situ forming implants","volume":"621","author":"Wang","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114793_bb0160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2019.05.003","article-title":"Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formation","volume":"304","author":"Park","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114793_bb0165","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijpharm.2015.08.063","article-title":"A protocol for assay of poly(lactide-co-glycolide) in clinical products","volume":"495","author":"Garner","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114793_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120627","article-title":"Analysis of semi-solvent effects for PLGA polymers","volume":"602","author":"Garner","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114793_bb0175","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jconrel.2019.03.002","article-title":"Complex sameness: separation of mixed poly(lactide-co-glycolide)s based on the lactide:glycolide ratio","volume":"300","author":"Skidmore","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114793_bb0180","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/mrc.2195","article-title":"Z-restored spin-echo 13 C 1D spectrum of straight baseline free of hump, dip and roll","volume":"46","author":"Xia","year":"2008","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.jconrel.2026.114793_bb0185","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/app.22135","article-title":"Predictors of glass transition in the biodegradable poly-lactide and poly-lactide-co-glycolide polymers","volume":"100","author":"Park","year":"2006","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.jconrel.2026.114793_bb0190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jconrel.2013.12.020","article-title":"Solvent induced phase inversion-based in situ forming controlled release drug delivery implants","volume":"176","author":"Thakur","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114793_bb0195","series-title":"Strategies to Modify the Drug Release from Pharmaceutical Systems","first-page":"63","article-title":"Mathematical models of drug release","year":"2015"},{"key":"10.1016\/j.jconrel.2026.114793_bb0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejps.2014.10.002","article-title":"In vitro dissolution similarity factor (f2) and in vivo bioequivalence criteria, how and when do they match? Using a BCS class II drug as a simulation example","volume":"66","author":"Xie","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.114793_bb0205","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/molecules26020437","article-title":"High-performance liquid chromatography-tandem mass spectrometry for buprenorphine evaluation in plasma\u2014application to pharmacokinetic studies in rabbits","volume":"26","author":"Tikhomirov","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2026.114793_bb0210","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1208\/s12249-008-9050-z","article-title":"Solubility improvement of drugs using N-methyl pyrrolidone","volume":"9","author":"Sanghvi","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2026.114793_bb0215","unstructured":"Sublocade\u00ae, Clinical Pharmacology and biopharmaceutics review. Application number: 209819Orig1s000, Food and Drug Administration (2017). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2017\/209819Orig1s000StatR.pdf (accessed February 25, 2025)."},{"key":"10.1016\/j.jconrel.2026.114793_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126006","article-title":"Long-acting injectable buprenorphine PLGA microparticle formulation","volume":"683","author":"Otte","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114793_bb0225","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0378-5173(02)00187-4","article-title":"Polymer erosion in PLGA microparticles produced by phase separation method","volume":"242","author":"Husmann","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114793_bb0230","doi-asserted-by":"crossref","first-page":"16352","DOI":"10.1021\/ja306866w","article-title":"The effect of monomer order on the hydrolysis of biodegradable poly(lactic- co -glycolic acid) repeating sequence copolymers","volume":"134","author":"Li","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.114793_bb0235","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s13346-021-01023-3","article-title":"Characterization of commercial PLGAs by NMR spectroscopy","volume":"12","author":"Sun","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2026.114793_bb0240","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.biomaterials.2016.11.037","article-title":"The impact of monomer sequence and stereochemistry on the swelling and erosion of biodegradable poly(lactic-co-glycolic acid) matrices","volume":"117","author":"Washington","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114793_bb0245","doi-asserted-by":"crossref","first-page":"7132","DOI":"10.1021\/ma201169z","article-title":"A strategy for control of \u201crandom\u201d copolymerization of lactide and Glycolide: application to synthesis of PEG-b-PLGA block polymers having narrow dispersity","volume":"44","author":"Qian","year":"2011","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2026.114793_bb0250","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1021\/bm301900t","article-title":"Mechanistic studies on the degradation and protein release characteristics of poly(lactic- co -glycolic- co -hydroxymethylglycolic acid) nanospheres","volume":"14","author":"Samadi","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.114793_bb0255","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.memsci.2016.04.069","article-title":"Understanding the non-solvent induced phase separation (NIPS) effect during the fabrication of microporous PVDF membranes via thermally induced phase separation (TIPS)","volume":"514","author":"Jung","year":"2016","journal-title":"J. Membr. Sci."},{"key":"10.1016\/j.jconrel.2026.114793_bb0260","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1021\/ie101928r","article-title":"Preparation and characterization of membranes formed by nonsolvent induced phase separation: a review","volume":"50","author":"Guillen","year":"2011","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.jconrel.2026.114793_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118703","article-title":"Long lasting in-situ forming implant loaded with raloxifene HCl: an injectable delivery system for treatment of bone injuries","volume":"571","author":"Elkasabgy","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114793_bb0270","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jconrel.2015.09.052","article-title":"In vitro\u2013in vivo correlation for complex non-oral drug products: where do we stand?","volume":"219","author":"Shen","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114793_bb0275","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/pharmaceutics8030028","article-title":"An accelerated release study to evaluate long-acting contraceptive levonorgestrel-containing in situ forming depot systems","volume":"8","author":"Janagam","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114793_bb0280","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jconrel.2007.05.034","article-title":"Effect of acidic pH on PLGA microsphere degradation and release","volume":"122","author":"Zolnik","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114793_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120105","article-title":"Effect of implant formation on drug release kinetics of in situ forming implants","volume":"592","author":"Suh","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114793_bb0290","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s13346-022-01177-8","article-title":"In vitro degradation and erosion behavior of commercial PLGAs used for controlled drug delivery","volume":"13","author":"Walker","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2026.114793_bb0295","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jconrel.2010.01.001","article-title":"Noninvasive characterization of in situ forming implants using diagnostic ultrasound","volume":"143","author":"Solorio","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114793_bb0300","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1021\/acs.molpharmaceut.2c00945","article-title":"Influence of PLGA end groups on the release profile of dexamethasone from ocular implants","volume":"20","author":"Saraf","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.114793_bb0305","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1124\/dmd.105.003681","article-title":"In vitro metabolism study of buprenorphine: evidence for new metabolic pathways","volume":"33","author":"Picard","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2026.114793_bb0315","series-title":"Application Number: 209819orig1s000 Clinical Pharmacology And Biopharmaceutics Review(S)","author":"Center for Drug Evaluation and Research","year":"2026"},{"key":"10.1016\/j.jconrel.2026.114793_bb0320","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jconrel.2022.05.014","article-title":"In vitro-in vivo correlation of PLGA microspheres: effect of polymer source variation and temperature","volume":"347","author":"Wan","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114793_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123170","article-title":"In vivo characterization of Perseris and compositionally equivalent formulations","volume":"642","author":"Wang","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114793_bb0330","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1208\/s12248-012-9397-7","article-title":"Use of partial area under the curve metrics to assess bioequivalence of methylphenidate multiphasic modified release formulations","volume":"14","author":"Stier","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2026.114793_bb0335","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0928-0987(97)10023-9","article-title":"Evaluation of different partial AUCs as indirect measures of rate of drug absorption in comparative pharmacokinetic studies","volume":"6","author":"Duquesnoy","year":"1998","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926001951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926001951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:06:23Z","timestamp":1781715983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926001951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":64,"alternative-id":["S0168365926001951"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114793","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic approach to develop and characterize a compositionally equivalent buprenorphine in situ forming implant (Sublocade\u00ae)","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114793"}}